Lincoln National Corp’s CRISPR Therapeutics CRSP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-8,618
| Closed | -$587K | – | 219 |
|
|
2024
Q1 | $587K | Sell |
8,618
-882
| -9% | -$60.1K | 0.01% | 691 |
|
|
2023
Q4 | $595K | Buy |
+9,500
| New | +$595K | 0.01% | 617 |
|
|
2021
Q3 | – | Sell |
-1,590
| Closed | -$257K | – | 872 |
|
|
2021
Q2 | $257K | Buy |
+1,590
| New | +$257K | 0.01% | 729 |
|
|
2021
Q1 | – | Sell |
-1,531
| Closed | -$234K | – | 810 |
|
|
2020
Q4 | $234K | Buy |
+1,531
| New | +$234K | 0.01% | 653 |
|